| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9016461 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2005 | 7 Pages |
Abstract
The results of this study suggest that allopurinol may be an effective adjuvant agent in the management of patients with chronic schizophrenia. Nevertheless, results of larger controlled trials are needed, before recommendations for a broad clinical application can be made.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Shahin Akhondzadeh, Anosheh Safarcherati, Homayoun Amini,